TENAX THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.48 USD | -3.33% |
|
-4.13% | -84.16% |
Chart calendar Tenax Therapeutics, Inc.
48af8100b12c9a09c3d.MlYoaOXmRoCqtSnyrSVYEzRXAvZnqYASxx2fblnjbX0.UDobEIOUJObpgEa65W4Hfn8TdscJ2813tEXWGW2mOhxmDGIRtao11-vETg~94656a63fa2be3a36f19fdf69400301a
Upcoming events on Tenax Therapeutics, Inc.
Past events on Tenax Therapeutics, Inc.
| 18/04/2024 15:00 | Investor Meeting - Key Opinion Leader |
| 28/03/2024 12:30 | Q4 2023 Earnings Release |
| 18/03/2024 22:00 | ROTH Conference |
| 06/03/2024 14:39 | Technology and Heart Failure Therapeutics Conference |
| 02/01/2024 | Reverse Split: 1 of 80 |
| 29/11/2023 | Extraordinary Shareholders Meeting |
| 04/01/2023 | Reverse Split: 1 of 20 |
| 01/04/2022 | American College of Cardiology Meeting |
| 31/03/2022 13:30 | FY 2021 Earnings Release |
| 04/01/2022 | LifeSci Partners Corporate Access Event |
| 16/11/2021 13:30 | Q3 2021 Earnings Release |
| 29/09/2021 18:35 | Benziga Healthcare Small Cap Conference |
| 13/09/2021 12:00 | H.C. Wainwright Global Investment Conference |
| 17/08/2021 13:00 | Interim 2021 Earnings Release |
| 16/08/2021 15:00 | Investor Meeting - Key Opinion Leader |
| 09/06/2021 | Annual General Meeting |
| 17/05/2021 22:15 | Q1 2021 Earnings Release |
| 31/03/2021 21:45 | FY 2020 Earnings Release |
| 09/03/2021 12:00 | H.C. Wainwright Global Life Science Conference |
| 21/01/2021 21:30 | Acquisition of PH Precision Med by Tenax Therapeutics, Inc Management Discussion Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -9,86 -8,90 -10.83% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,56 -8,25 -3.7% | -9,87 -8,90 -10.88% | -32,7 -33,6 2.45% | -11,1 -12,0 7.92% | -8,23 -7,39 -11.47% | -16,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,39 -8,40 0.07% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,71 -7,18 -7.35% | -16,2 |
|
Net income Million USD | Released Forecast Spread | -8,39 -11,9 29.16% | -9,85 -8,90 -10.69% | -32,5 -33,5 2.92% | -11,0 -12,0 7.96% | -7,71 -7,18 -7.35% | -16,2 |
|
EPS USD | Released Forecast Spread | -2 160 -2 488 13.18% | -2 128 -1 352 -57.4% | -2 528 -2 600 2.77% | -601 -745 19.33% | -31,0 -28,8 -7.78% | -7,43 |
| Announcement Date | 30/03/20 | 31/03/21 | 29/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million USD | Released Forecast Spread | -3,21 -4,05 20.7% | -2,86 -2,50 -14.48% | -2,92 -3,25 10.23% | -2,55 -3,50 27.09% | -1,54 -2,63 41.53% | -1,24 -2,07 40.15% | -2,12 -2,60 18.56% | -3,34 -2,49 -34.15% | -3,51 | -3,23 | -3,64 | -3,96 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,21 -4,05 20.73% | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -3,23 -2,49 -29.52% | -3,51 | -3,23 | -3,64 | -3,96 | |
|
Net income Million USD | Released Forecast Spread | -3,21 -4,05 20.73% | -2,72 | -2,86 -2,50 -14.44% | -2,92 -3,25 10.26% | -2,55 -3,50 27.25% | -1,41 -2,63 46.57% | -1,11 -2,07 46.44% | -1,97 -2,60 24.15% | -3,23 -2,49 -29.52% | -3,51 | -3,23 | -3,64 | -3,96 |
|
EPS USD | Released Forecast Spread | -64,0 -256 75% | -176 | -176 -144 -22.22% | -176 -168 -4.76% | -72,8 -212 65.73% | -12,0 -29,6 59.46% | -4,00 -8,00 50% | -6,40 -9,60 33.33% | -8,64 -8,15 -6.08% | -2,40 | -1,65 | -1,77 | -1,19 |
| Announcement Date | 29/03/22 | 16/05/22 | 11/08/22 | 10/11/22 | 31/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 28/03/24 | - | - | - | - |
| Today 21:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 11:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 11:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 12:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 01/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Tenax Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TENX Stock
- Calendar Tenax Therapeutics, Inc.
